Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

8.99
Delayed Data
As of May 27
 +0.325 / +3.75%
Today’s Change
5.05
Today|||52-Week Range
9.00
+14.23%
Year-to-Date
Yellen's Words of Warning Don't Faze Market
May 27 / TheStreet.com - Paid Partner Content
Earnings Estimates Moving Higher for Neogenomics (NEO): Time to Buy?
May 26 / Zacks.com - Paid Partner Content
Janet Yellen Could Upset Things Very Easily
May 27 / TheStreet.com - Paid Partner Content
Integra Unveils Fin-Lock Glenoid, Boosts Shoulder Arthroplasty
May 24 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close8.66
Today’s open8.66
Day’s range8.63 - 9.00
Volume1,040,394
Average volume (3 months)359,566
Market cap$677.1M
Dividend yield--
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-300.00%
Earnings growth (this year)+104.76%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+14.62%
P/E ratioNM
Price/Sales4.77
Price/Book3.18

Competitors

 Today’s
change
Today’s
% change
NVTAInvitae Corp+0.09+0.96%
GNMKGenMark Diagnostics ...+0.17+2.38%
RDNTRadNet Inc+0.11+2.14%
PTIProteostasis Therape...+0.49+3.18%
Data as of 4:02pm ET, 05/27/2016

Financials

Next reporting dateJuly 14, 2016
EPS forecast (this quarter)$0.03
Annual revenue (last year)$99.8M
Annual profit (last year)-$2.5M
Net profit margin-2.54%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. Van Oort
Chief Operating Officer
Robert J. Shovlin
Corporate headquarters
Fort Myers, Florida

Forecasts

Partner Offers

Search for Jobs